# KBIOGATEWAY

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kbiogateway

- Industry: Biotechnology
- Headquarters: Cheonan-si, South Korea
- Total disclosed funding: $0.9M
- Latest round: Seed (Sep 21, 2026)
- Investors on record: 3

## About

Based in Chungcheongnam, South Korea, and founded in 2025 by Cho Kyung-won, KBIOGATEWAY, is a green biotech startup specializing in the research and development of functional bio-materials for health and wellness. The company focuses on metabolic disease-related applications and has developed its flagship probiotic strain, DH24 (Lactiplantibacillus plantarum DH24), derived from human breast milk. DH24 was discovered by CEO Kyung-won Cho, who previously participated in the development of successful probiotic products in Korea. In September 2026, KBIOGATEWAY completed a KRW 1.2 billion Seed financing round led by Korea Technology Finance Corporation (KOTEC) with participation from Bluepoint Partners and YNARCHER.
The company focuses on developing functional probiotic ingredients and health-related bio-materials based on its proprietary DH24 strain. DH24 is a probiotic designed to support body fat reduction and anti-inflammatory metabolism, and serves as the core ingredient for the company's functional food and cosmetic ingredient development efforts. KBIOGATEWAY also operates the consumer brand Diet Helper 24, which commercializes products utilizing the DH24 probiotic platform.
The company's revenue is generated by the development and commercialization of probiotic-based functional ingredients, dietary supplements, and related health and beauty products utilizing its proprietary DH24 strain. Future revenue growth is expected to come from ingredient licensing, branded consumer products, and commercialization of functional food and cosmetic materials.
The company will use funding for DH24-based product research and development, expansion of production capabilities, global clinical studies, and regulatory approval processes to support international market entry and commercialization efforts. Management stated that the financing will accelerate the development and business expansion of DH24 and support the company's global growth strategy.

## Funding rounds

- Seed, Sep 21, 2026, $0.9M — Korea Technology Finance Corporation, Bluepoint Partners, Y&ARCHER

## Investors

- Korea Technology Finance Corporation — Seed
- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Y&ARCHER (https://capitalatlas.ai/funds/y-archer) — Seed